Therapeutic targeting of the endothelin-A receptor in human ovarian carcinoma: efficacy of cytotoxic agents is markedly enhanced by co-administration with atrasentan.

Source:http://linkedlifedata.com/resource/pubmed/id/15838262

Download in:

View as

General Info

PMID
15838262